With the development of small-molecule FAP inhibitors such as 18F-labeled AlF-FAPI, research on the relationship between the abnormality of ventricular wall motion and the alteration of myocardial fibrosis has become feasible using PET imaging technology. Here, FAP is linked to Myocardial fibrosis.